I have a 47-year-old male patient with recurrent lower urinary tract symptoms (LUTS) and microhematuria. Intravenous pyelogram revealed normal urinary tract and 3-cm bladder tic. Cystoscopy revealed ...

We designed a study to determine if atypical verruciform lesions contain molecular perturbations and if so, are they linked to keratinizing squamous cell carcinomas or do they reflect an alternate ...

Acral melanoma among the minority population in Hawaii and the Pacific basin: Analysis of downstream effectors within the PI3K pathway. Identification of novel melanoma gene expression signatures ...

Approval of penpulimab-kcqx marks the company’s US regulatory debut and introduces a new immunotherapy option for advanced nasopharyngeal carcinoma. The FDA has approved Akeso’s penpulimab-kcqx, a ...

Therefore, in the case of an unknown primary, we would recommend HPV-specific testing. What other important consideration that our committee felt was important to clarify was that in the unknown ...

Penpulimab-kcqx is approved for first-line treatment of recurrent or metastatic non-keratinizing NPC in combination with cisplatin or carboplatin and gemcitabine. As a single agent, penpulimab-kcqx is ...